Biocon CFO Indranil Sen Resigns

Written by Divyani Paul Published On 2024-03-16T14:46:19+05:30 | Updated On 16 March 2024 2:46 PM IST

Bangalore- Indranil Sen, Chief Financial Officer (CFO) of Bengaluru-based Indian biopharmaceutical company Biocon, has resigned from his post effective from March 16, 2024.

Indranil obtained his Chartered Accountant qualification from the Institute of Chartered Accountants of India, New Delhi.

He joined Biocon 2014, after which he held various positions in the finance department. Mr Sen was appointed Chief Financial Officer (CFO) in April 2021 after Anupam Jindal stepped down from the post of CFO.

Indranil possesses more than two decades of extensive expertise in financial planning, treasury management, taxation, and financial reporting. His professional journey commenced in statutory audit, where he contributed to renowned firms such as B S R & Co. (the Indian division of KPMG) in Kolkata and S R Batliboi & Co. (the Indian branch of Ernst & Young) in Bengaluru.

Before joining Biocon, he held the position of Director of Finance at Symphony Teleca, a well-known multinational IT corporation headquartered in the United States.

Chief Financial OfficerCFObiopharmaceuticalBioconIndranil SenAnupam Jindal

Source : With Inputs

Divyani Paul

I am a student of Journalism and Mass Communication and also a passionate writer and explorer. With a keen interest in medicine, I have joined Medical Dialogues as a Content Writer. Within this role, I curate various healthcare-related news including the latest updates on health, hospitals, and regulatory updates from NMC/DCI. For any query or information, feel free to reach out to me at editorial@medicaldialogues.in